Dr. Scott Gottlieb
Also: Jonathan Bush, Dr. Scott Gottlieb embrace the board of directors.
According to the Washington Post, which broke the news, the commissioner is leaving to spend more time with his family.
Released yesterday, the document outlines FDA's preference toward single applications for combination products.
The new guidance aims to modernize the process and generate more market competition.
At AcademyHealth’s 2018 Health Datapalooza on Thursday, the US Food and Drug Administration offered a vote of confidence for artificial intelligence in healthcare, promising more refined strategies for regulation, touting its tech incubator for AI innovation, and announcing a new machine learning partnership with Harvard.